The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease
Open accessAbstract
BACKGROUND: The treatment of symptomatic congenital cytomegalovirus (CMV) disease with intravenous ganciclovir for 6 weeks has been shown to improve audiologic outcomes at 6 months, but the benefits wane over time. METHODS: We conducted a randomized, placebo-controlled trial of valganciclovir therapy in neonates with symptomatic congenital CMV disease, comparing 6 months of therapy with 6 weeks of therapy. The primary end point was the change in hearing in the better ear ("best-ear" hearing) from baseline to 6 months. Secondary end points included the change in hearing from baseline to follow-up at 12 and 24 months and neurodevelopmental outcomes, with each end point adjusted for central nervous system involvement at baseline. RESULTS: A total of 96 neonates underwent randomization, of whom 86 had follow-up data at 6 months that could be evaluated. Best-ear hearing at 6 months was similar in the 6-month group and the 6-week group (2 and 3 participants, respectively, had improvement; 36 and 37 had no change; and 5 and 3 had worsening; P=0.41). Total-ear hearing (hearing in one or both ears that could be evaluated) was more likely to be improved or to remain normal at 12 months in the 6-month group than in the 6-week group (73% vs. 57%, P=0.01). The benefit in total-ear hearing was maintained at 24 months (77% vs. 64%, P=0.04). At 24 months, the 6-month group, as compared with the 6-week group, had better neurodevelopmental scores on the Bayley Scales of Infant and Toddler Development, third edition, on the language-composite component (P=0.004) and on the receptive-communication scale (P=0.003). Grade 3 or 4 neutropenia occurred in 19% of the participants during the first 6 weeks. During the next 4.5 months of the study, grade 3 or 4 neutropenia occurred in 21% of the participants in the 6-month group and in 27% of those in the 6-week group (P=0.64). CONCLUSIONS: Treating symptomatic congenital CMV disease with valganciclovir for 6 months, as compared with 6 weeks, did not improve hearing in the short term but appeared to improve hearing and developmental outcomes modestly in the longer term. (Funded by the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT00466817.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection
Kenneson, A., & Cannon, M. J. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.535 · Cited by 1,720
Newborn Hearing Screening — A Silent Revolution
Morton, C. C., & Nance, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050700 · Cited by 1,686
Dollard, S. C., Grosse, S. D., & Ross, D. S. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.544 · Cited by 1,257
The “Silent” Global Burden of Congenital Cytomegalovirus
Manicklal, S., Emery, V. C., Lazzarotto, T., Boppana, S. B., & Gupta, R. K. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00062-12 · Cited by 1,028
Kimberlin, D. W., Lin, C.-Y., Sánchez, P. J., Demmler, G. J., Dankner, W., Shelton, M., Jacobs, R. F., Vaudry, W., Pass, R. F., Kiell, J. M., et al. (2003) · The Journal of Pediatrics · doi:10.1016/s0022-3476(03)00192-6 · Cited by 987
Self-citationFowler, K. B., McCollister, F. P., Dahle, A. J., Boppana, S., Britt, W. J., & Pass, R. F. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70248-8 · Cited by 549
Longitudinal Investigation of Hearing Disorders in Children with Congenital Cytomegalovirus
Dahle, A. J., Fowler, K. B., Wright, J. D., Boppana, S. B., Britt, W. J., & Pass, R. F. (2000) · Journal of the American Academy of Audiology · doi:10.1055/s-0042-1748054 · Cited by 442
Congenital cytomegalovirus (CMV) infection and hearing deficit
Fowler, K. B., & Boppana, S. B. (2006) · Journal of Clinical Virology · doi:10.1016/j.jcv.2005.09.016 · Cited by 392
Boppana, S. B. (2010) · JAMA · doi:10.1001/jama.2010.423 · Cited by 383
Grosse, S. D., Ross, D. S., & Dollard, S. C. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.09.004 · Cited by 364
Cited by
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Marty, F. M., Ljungman, P., Chemaly, R. F., Maertens, J., Dadwal, S. S., Duarte, R. F., Haider, S., Ullmann, A. J., Katayama, Y., Brown, J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706640 · Cited by 1,238
Rawlinson, W. D., Boppana, S. B., Fowler, K. B., Kimberlin, D. W., Lazzarotto, T., Alain, S., Daly, K., Doutré, S., Gibson, L., Giles, M. L., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30143-3 · Cited by 841
Self-citationKorver, A. M. H., Smith, R. J. H., Van Camp, G., Schleiss, M. R., Bitner-Glindzicz, M. A. K., Lustig, L. R., Usami, S.-I., & Boudewyns, A. N. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.94 · Cited by 539
Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management
Luck, S. E., Wieringa, J. W., Blázquez-Gamero, D., Henneke, P., Schuster, K., Butler, K., Capretti, M. G., Cilleruelo, M. J., Curtis, N., Garofoli, F., et al. (2017) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001763 · Cited by 309
Self-citationSsentongo, P., Hehnly, C., Birungi, P., Roach, M. A., Spady, J., Fronterre, C., Wang, M., Murray-Kolb, L. E., Al-Shaar, L., Chinchilli, V. M., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.20736 · Cited by 258
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
Tompa, D. R., Immanuel, A., Srikanth, S., & Kadhirvel, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.076 · Cited by 257
Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes
Panchaud, A., Stojanov, M., Ammerdorffer, A., Vouga, M., & Baud, D. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00014-16 · Cited by 171
Viral Etiology of Sudden Sensorineural Hearing Loss: Historical Development and Current Evidence
Zhao, S., Liu, X., Shi, X., Zhao, Z., & Sun, Y. (2026) · Viruses · doi:10.3390/v18101097
Metadata
- Authors
- Kimberlin, D. W., Jester, P. M., Sánchez, P. J., Ahmed, A., Arav-Boger, R., Michaels, M. G., Ashouri, N., Englund, J. A., Estrada, B., Jacobs, R. F., Romero, J. R., Sood, S. K., Whitworth, M. S., Abzug, M. J., Caserta, M. T., Fowler, S., Lujan-Zilbermann, J., Storch, G. A., DeBiasi, R. L., Han, J.-Y., Palmer, A., Weiner, L. B., Bocchini, J. A., Dennehy, P. H., Finn, A., Griffiths, P. D., Luck, S., Gutierrez, K., Halasa, N., Homans, J., Shane, A. L., Sharland, M., Simonsen, K., Vanchiere, J. A., Woods, C. R., Sabo, D. L., Aban, I., Kuo, H., James, S. H., Prichard, M. N., Griffin, J., Giles, D., Acosta, E. P., & Whitley, R. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-03-05
- Volume
- 372
- Issue
- 10
- Pages
- 933-943
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1551094585
- Cited by
- 827
- References
- 17
- FWCI
- 52.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.